Otc drug and dietary supplement market to reach $497.84 billion by 2030 at 7.2% cagr, driven by rising pharma research and development expenditure globally.
Read More
Osteoporosis drugs market to reach $16.21 billion by 2030 at 4.3% cagr, driven by surging prevalence of osteoporosis among aging populations worldwide.
Read More
Osteogenesis imperfecta treatment market to reach $1.16 billion by 2030 at 4.3% cagr, driven by increasing prevalence of osteogenesis imperfecta due to improved genetic diagnosis.
Read More
Osimertinib drugs market to reach $16.25 billion by 2030 at 16.1% cagr, driven by increasing incidence of lung cancer and rising organizational initiatives to improve cancer care.
Read More
Orphan drugs service market to reach $93.93 billion by 2030 at 16.6% cagr, driven by growing investment in rare diseases and increased funding for research and development.
Read More
Orphan drugs market to reach $794.12 billion by 2030 at 28.2% cagr, driven by rising prevalence of rare diseases globally and increasing diagnosis rates.
Read More
Organic pharmaceutical excipients market to reach $18.99 billion by 2030 at 9.3% cagr, driven by rising demand for pharmaceutical drugs due to growing burden of chronic and complex health conditions.
Read More
Organ transplant immunosuppressant drugs market to reach $6.85 billion by 2030 at 4.8% cagr, driven by increasing demand for organ transplantation.
Read More
Orencia abatacept drug market to reach $5.28 billion by 2030 at 6.1% cagr, driven by increasing prevalence of autoimmune diseases and rising personalized medicine.
Read More
Orally disintegrating tablet market to reach $24.43 billion by 2030 at 8.5% cagr, driven by increasing incidence of neurological disorders.
Read More